Serveur d'exploration sur les pandémies grippales

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Voie intranasale And NotRebecca J. Cox

List of bibliographic references

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000078 Anna-Karin Maltais [Suède] ; Koert J. Stittelaar [Pays-Bas] ; Edwin J. B. Veldhuis Kroeze [Pays-Bas] ; Geert Van Amerongen [Pays-Bas] ; Marcel L. Dijkshoorn [Pays-Bas] ; Gabriel P. Krestin [Pays-Bas] ; Jorma Hinkula [Suède] ; Hans Arwidsson [Suède] ; Alf Lindberg [Suède] ; Albert D. M. E. Osterhaus [Pays-Bas]Intranasally administered Endocine formulated 2009 pandemic influenza H1N1 vaccine induces broad specific antibody responses and confers protection in ferrets
000079 A. Morokutti [Autriche] ; T. Muster [Autriche] ; B. Ferko [Autriche]Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans
000080 Edgar Turner Overton [États-Unis] ; Paul A. Goepfert [États-Unis] ; Pamela Cunningham [États-Unis] ; William A. Carter [États-Unis] ; Joseph Horvath [États-Unis] ; Diane Young [États-Unis] ; David R. Strayer [États-Unis]Intranasal seasonal influenza vaccine and a TLR-3 agonist, rintatolimod, induced cross-reactive IgA antibody formation against avian H5N1 and H7N9 influenza HA in humans
000118 Mookkan Prabakaran [Singapour] ; SUBASCHANDRABOSE RAJESH KUMAR [Singapour] ; KATTUR VENKATACHALAM ASHOK RAJ [Singapour] ; XIAPENG WU [Singapour, République populaire de Chine] ; FANG HE [Singapour] ; JIYONG ZHOU [République populaire de Chine] ; Jimmy Kwang [Singapour]Cross-protective efficacy of baculovirus displayed hemagglutinin against highly pathogenic influenza H7 subtypes
001140 Takeshi Ichinohe [Japon] ; Akira Ainai [Japon] ; Yasushi Ami [Japon] ; Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Akira Kawaguchi [Japon] ; Yuriko Suzaki [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Hidehiro Takahashi [Japon] ; David R. Strayer [États-Unis] ; William A. Carter [États-Unis] ; Joe Chiba [Japon] ; Shin-Ichi Tamura [Japon] ; Tetsutaro Sata [Japon] ; Takeshi Kurata [Japon] ; Hideki Hasegawa [Japon]Intranasal Administration of Adjuvant-Combined Vaccine Protects Monkeys From Challenge With the Highly Pathogenic Influenza A H5N1 Virus
001302 PENGHUI YANG [République populaire de Chine] ; CHONG TANG [République populaire de Chine] ; DEYAN LUO [République populaire de Chine] ; ZHONGPENG ZHAN [République populaire de Chine] ; LI XING [République populaire de Chine] ; YUEQIANG DUAN [République populaire de Chine] ; WEIHONG JIA [République populaire de Chine] ; DAXIN PENG [République populaire de Chine] ; XIUFAN LIU [République populaire de Chine] ; XILIANG WANG [République populaire de Chine]Cross-clade protection against HPAI H5N1 influenza virus challenge in BALB/c mice intranasally administered adjuvant-combined influenza vaccine
001380 Saori Sakabe [Japon] ; Kiyoko Iwatsuki-Horimoto [Japon] ; Taisuke Horimoto [Japon] ; Chairul A. Nidom [Indonésie] ; Mai Thi Quynh Le [Viêt Nam] ; Ryo Takano [Japon] ; Ritsuko Kubota-Koketsu [Japon] ; Yoshinobu Okuno [Japon] ; Makoto Ozawa [Japon, États-Unis] ; Yoshihiro Kawaoka [Japon, États-Unis]A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1 N1 ) 2009 virus infection
001467 Graeme E. Price [États-Unis] ; Mark R. Soboleski [États-Unis] ; Chia-Yun Lo [États-Unis] ; Julia A. Misplon [États-Unis] ; Claudia Pappas [États-Unis] ; Katherine V. Houser [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Suzanne L. Epstein [États-Unis]Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses
001547 Takeshi Ichinohe [Japon, États-Unis] ; Akira Ainai [Japon] ; Masato Tashiro [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]PolyI:polyC12U adjuvant-combined intranasal vaccine protects mice against highly pathogenic H5N1 influenza virus variants
001625 Yoshitaka Kashima [Japon] ; Mizuho Ikeda [Japon] ; Yasushi Itoh [Japon] ; Yoshihiro Sakoda [Japon] ; Tomoya Nagata [Japon] ; Taichiro Miyake [Japon] ; Kosuke Soda [Japon] ; Hiroichi Ozaki [Japon] ; Misako Nakayama [Japon] ; Hitomi Shibuya [Japon] ; Masatoshi Okamatsu [Japon] ; Hirohito Ishigaki [Japon] ; Hideaki Ishida [Japon] ; Toshihiro Sawai [Japon] ; Yoshihiro Kawaoka [Japon, États-Unis] ; Hiroshi Kida [Japon] ; Kazumasa Ogasawara [Japon]Intranasal administration of a live non-pathogenic avian H5N1 influenza virus from a virus library confers protective immunity against H5N1 highly pathogenic avian influenza virus infection in mice: Comparison of formulations and administration routes of vaccines
001626 Lucy A. Perrone [États-Unis] ; Attiya Ahmad [États-Unis] ; Vic Veguilla [États-Unis] ; XIUHUA LU [États-Unis] ; Gale Smith [États-Unis] ; Jacqueline M. Katz [États-Unis] ; Peter Pushko [États-Unis] ; Terrence M. Tumpey [États-Unis]Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge
001627 Daniela Kugel [Allemagne] ; Georg Kochs [Allemagne] ; Karola Obojes [Canada] ; Joachim Roth [Allemagne] ; Gary P. Kobinger [Canada] ; Darwyn Kobasa [Canada] ; Otto Haller [Allemagne] ; Peter Staeheli [Allemagne] ; Veronika Von Messling [Canada]Intranasal Administration of Alpha Interferon Reduces Seasonal Influenza A Virus Morbidity in Ferrets
001A46 Takeshi Ichinohe [Japon] ; Shin-Ichi Tamura [Japon] ; Akira Kawaguchi [Japon] ; Ai Ninomiya [Japon] ; Masaki Imai [Japon] ; Shigeyuki Itamura [Japon] ; Takato Odagiri [Japon] ; Masato Tashiro [Japon] ; Hidehiro Takahashi [Japon] ; Hirofumi Sawa [Japon] ; William M. Mitchell [États-Unis] ; David R. Strayer [États-Unis] ; William A. Carter [États-Unis] ; Joe Chiba [Japon] ; Takeshi Kurata [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine
001A71 Michael Vajdy [États-Unis] ; Barbara Baudner [Italie] ; Giuseppe Del Giudice [Italie] ; Derek O'Hagan [États-Unis]A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza
001D31 DAQING WANG [Canada] ; Mary E. Christopher [Canada] ; Les P. Nagata [Canada] ; Monika A. Zabielski [Canada] ; HONGDUO LI [Canada] ; Jonathan P. Wong [Canada] ; John Samuel [Canada]Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses
001D64 Ayato Takada [Japon] ; Sachiko Matsushita [Japon] ; Ai Ninomiya [Japon] ; Yoshihiro Kawaoka [Japon] ; Hiroshi Kida [Japon]Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021